Evidence - Anesthesia examination, Pap smear, LEEP conization, cystoscopy, hysteroscopy, fractional curettage, rectoscopy

Cervical cancer is one of the most common malignant diseases in women worldwide. The main cause is a persistent infection with high-risk HPV. The incidence of invasive carcinomas has been significantly reduced in recent decades through the cytological early detection program (Pap smear). Nevertheless, especially in cases of inadequate screening, advanced stages also occur. Guideline-compliant diagnostics and therapy are based on the tumor stage (FIGO classification) and individual risk factors.

Reference:

1. Guideline Program Oncology (German Cancer Society, German Cancer Aid, AWMF): S3 Guideline Diagnostics, Therapy and Follow-up Care of Patients with Cervical Cancer, Long Version, 2.2, 2022, AWMF Register Number: 032/033OL
2. Fehm T, Beckmann MW, Mahner S, Denschlag D, Brucker S, Hillemanns P, Tempfer C; Uterus Commission of the AGO and the AGO Working Group. Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Surgical Therapy for Patients with Stage IA2-IIB1 Cervical Cancer. Geburtshilfe Frauenheilkd. 2023 Oct 5;83(10):1199-1204. doi: 10.1055/a-2160-3279. PMID: 37808259; PMCID: PMC10556864.